New antibody-chemo combo offers hope for kids with aggressive nerve cancer
NCT ID NCT07549321
First seen Apr 29, 2026 · Last updated May 07, 2026 · Updated 2 times
Summary
This study tests whether adding an antibody called hu14.18K322A to standard chemotherapy can better shrink or eliminate tumors in children and teens with high-risk neuroblastoma, a rare and aggressive nerve cancer. About 144 participants aged 18 months to under 18 years will receive the combination therapy. The main goals are to see how many patients achieve a complete or partial response and to monitor safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH RISK NEUROBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital Colorado Anschutz Medical
RECRUITINGAurora, Colorado, 80045, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Children's Hospital of Philadelphia
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.